Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Promissory Note out of Alberta
Dated: April 11, 2024.
Amt: $543,120.00 CAN
With 700K Warrants, Expire, April 11, 2029 @ $1.03.
Koo